Related Experiment Video
Updated: Mar 7, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Bile acids and cardiovascular function in cirrhosis
Andrei Voiosu1,2,3, Signe Wiese1,4, Theodor Voiosu2,3
1Department of Clinical Physiology and Nuclear Medicine, Center for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark.
Insights
Bile acids contribute to cardiovascular dysfunction in cirrhosis by altering signaling pathways. Targeting bile acid receptors may offer new therapeutic strategies for cirrhotic cardiomyopathy and hyperdynamic syndrome.
Area of Science:
- Cardiology
- Hepatology
- Pharmacology
Background:
- Cirrhotic cardiomyopathy and hyperdynamic syndrome are significant complications of cirrhosis with unclear pathogenesis.
- Bile acids are implicated in cardiovascular dysfunction, with emerging evidence on their receptor-mediated effects.
Purpose of the Study:
- To review the role of bile acids and their receptors in cardiovascular dysfunction in cirrhosis.
- To explore potential therapeutic targets related to bile acid signaling.
Main Methods:
- Literature review of experimental models and recent studies on bile acids and cardiovascular function in cirrhosis.
- Analysis of bile acid receptor functions (FXR, TGR5) in cardiovascular cells.
Main Results:
- Bile acids exert cardiotoxic effects and disrupt cellular metabolism via receptor signaling.
- Chronic cholestasis leads to abnormal bile acid levels, altering signaling and causing cardiovascular disturbances.
Conclusions:
- Bile acids and their receptors are key players in the development of cardiovascular dysfunction in cirrhosis.
- Targeting bile acid receptors presents a promising therapeutic avenue for managing these complications.
Abstract:
Cirrhotic cardiomyopathy and the hyperdynamic syndrome are clinically important complications of cirrhosis, but their exact pathogenesis is still partly unknown. Experimental models have proven the cardiotoxic effects of bile acids and recent studies of their varied receptor-mediated functions offer new insight into their involvement in cardiovascular dysfunction in cirrhosis. Bile acid receptors such as farnesoid X-activated receptor and TGR5 are currently under investigation as potential therapeutic targets in a variety of pathological conditions. These receptors have also recently been identified in cardiomyocytes, vascular endothelial cells and smooth muscle cells where they seem to play an important role in cellular metabolism. Chronic cholestasis leading to abnormal levels of circulating bile acids alters the normal signalling pathways and contributes to the development of profound cardiovascular disturbances. This review summarizes the evidence regarding the role of bile acids and their receptors in the generation of cardiovascular dysfunction in cirrhosis.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Atherosclerosis III: Management